CANF

Can Fite BioPharma News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Can Fite BioPharma Ltd CANF AMEX Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
-0.02 -0.88% 2.24 2.15 2.32 2.30 2.26 19:56:03
more quote information »

Recent News

Date Time Source Heading
8/06/20208:06IHNWFeaturedIntegrated Ventures Executes Term Sheet For 1 Million To Purchase 500 Mining Rigs And To Fund Roll-Up Business Strategy
8/05/202016:28EDGARReport of Foreign Issuer (6-k)
7/27/202007:10EDGARReport of Foreign Issuer (6-k)
7/27/202007:00BWCan-Fite Submits Investigational New Drug Application to..
7/27/202006:04EDGARNotice of Effectiveness (effect)
7/24/202016:31EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
7/20/202007:10EDGARReport of Foreign Issuer (6-k)
7/20/202007:00BWCan-Fite Completes Development of an Assay to Identify..
7/17/202016:30EDGARSmall Company Offering and Sale of Securities Without..
7/15/202007:08EDGARReport of Foreign Issuer (6-k)
7/15/202007:00BWCan-Fite Completes Phase II COVID-19 Protocol Based on FDA..
7/10/202016:31EDGARSecurities Registration (foreign Private Issuer) (f-1)
7/08/202010:42EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
7/08/202010:40EDGARReport of Foreign Issuer (6-k)
7/06/202008:09EDGARReport of Foreign Issuer (6-k)
7/06/202008:00BWCan-Fite Announces $3.4 Million Registered Direct Offering
6/30/202007:08EDGARReport of Foreign Issuer (6-k)
6/30/202007:00BWCan-Fite Announces Final Data Analysis from Phase II NASH..
6/19/202016:36EDGARSmall Company Offering and Sale of Securities Without..
6/19/202016:24EDGARStatement of Ownership (sc 13g)
6/19/202006:03EDGARStatement of Ownership (sc 13g)
6/12/202008:30EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
6/12/202008:04EDGARReport of Foreign Issuer (6-k)
6/10/202008:11EDGARReport of Foreign Issuer (6-k)
6/10/202008:00BWCan-Fite Announces $8.0 Million Registered Direct Offering
6/09/202007:05EDGARReport of Foreign Issuer (6-k)
6/09/202007:00BWFollowing Pre-IND Guidance from FDA Can-Fite to Advance..
6/08/202007:25BWCan-Fite Participating in BIO Digital International..
6/04/202007:22EDGARReport of Foreign Issuer (6-k)
6/04/202007:14BWCan-Fite Concludes Successful Meeting with European..
6/03/202007:00BWCan-Fite BioPharma to Hold Investor Webinar and Q&A Session..
6/01/202007:24EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
6/01/202007:07EDGARReport of Foreign Issuer (6-k)
6/01/202007:00BWCan-Fite Reports First Quarter 2020 Financial Results &..
5/28/202007:00BWCan-Fite to Host First Quarter 2020 Financial Results &..
5/21/202007:13EDGARReport of Foreign Issuer (6-k)
5/21/202007:00BWCan-Fite Receives Notice of Allowance for Namodenoson Patent..
5/18/202007:09EDGARReport of Foreign Issuer (6-k)
5/18/202007:00BWCan-Fite Reports Additional Findings from Successful Phase..
5/15/202007:29EDGARReport of Foreign Issuer (6-k)
5/15/202007:00BWCan-Fite Announces Pre-IND Submission to U.S. FDA for..
4/28/202016:32EDGARReport of Foreign Issuer (6-k)
4/27/202006:08EDGARReport of Foreign Issuer (6-k)
4/21/202016:34EDGARReport of Foreign Issuer (6-k)
4/14/202007:00BWCan Fite to Conduct Investor Call to Review Positive Phase..
4/13/202006:37EDGARReport of Foreign Issuer (6-k)
4/13/202006:30BWCan Fite Received Approval for COVID-19 Clinical Trial in..
4/08/202006:01EDGARNotice of Effectiveness (effect)
4/07/202016:37EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
4/07/202016:33EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
4/07/202009:12EDGARReport of Foreign Issuer (6-k)
See more news about this stock »


Your Recent History
AMEX
CANF
Can Fite B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.